Hearing Loss Trial, Recruiting NCT07393880 Sponsor: University of Dublin, Trinity College Condition: Hearing Loss
Back to Hearing Loss

Hearing Loss Trial, Recruiting

NCT07393880
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults between 18 and 80 years of age
  • People who have had ongoing tinnitus (ringing or noise in the ears) that they can hear subjectively, lasting more than 3 months but no longer than 5 years
  • People whose tinnitus is mainly tonal in nature (a steady tone or ringing), in one or both ears
  • People whose tinnitus severity falls within a specific mid-range on a standard questionnaire called the THI (confirm with trial site for exact score range)
  • People whose tinnitus can be partially covered by a masking sound at a specific hearing level range (confirm with trial site for technical details)
  • People who have not previously received any nerve-stimulation-based treatment for tinnitus
  • People who are able to attend eight treatment sessions over four weeks, plus follow-up appointments

Who may not be able to join:

  • People whose tinnitus has a physical, detectable cause (such as a sound the ears produce that others can hear), or tinnitus that is mainly triggered by body movements or muscle tension
  • People whose tinnitus pulses in time with their heartbeat
  • People who have a type of hearing loss related to the outer or middle ear (detected by ear canal or eardrum testing)
  • People with certain levels of hearing loss at specific sound frequencies, as measured by a standard hearing test (confirm with trial site for exact details)
  • People who started using a hearing aid within the past 90 days
  • People who have an active implanted medical device, such as a pacemaker, deep brain stimulator, or cochlear implant
  • People whose ears are particularly sensitive to loud sounds at a specific frequency (confirm with trial site for technical details)
  • People who have been diagnosed with a jaw joint disorder (temporomandibular joint disorder) or a nerve pain condition called occipital neuralgia
  • People with severe anxiety, as measured by a standard anxiety questionnaire
  • People with signs of significant cognitive (thinking or memory) difficulties, as measured by a standard screening test
  • People with severe depression symptoms, as measured by a standard depression questionnaire
  • People who have been diagnosed with Menière's disease (an inner ear condition)
  • People who are currently pregnant
  • People whose tinnitus is part of an active legal or compensation case
  • People with a history of hearing voices or sounds that are not real (auditory hallucinations)
  • People currently taking prescription medications that are likely to affect how the brain and nervous system respond to stimulation, such as certain antidepressants, sedatives, or other psychiatric or neurological drugs (confirm with trial site for specific medications)
  • People who are currently taking part in another clinical intervention study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +353 87 470 2835.

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Dublin, Trinity College
Registry
ClinicalTrials.gov
Start date
30 January 2026
Est. completion
30 September 2028

Where this trial is recruiting

🇮🇪 Ireland

Primary endpoints

Tinnitus Loudness (Visual Analogue Scale, VAS 0-100); Tinnitus Functional Index (TFI, 0-100); Tinnitus Handicap Inventory (THI, 0-100)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov